Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway.
Apoptosis has been shown to contribute to the development of acute and chronic renal failure. The antiapoptotic action of the heme oxygenase (HO) system may represent an important protective mechanism in kidney pathology. We examined whether the lack of HO-1 would influence apoptosis in clipped kidneys of two-kidney, one-clip (2K1C) rats. Five-day-old Sprague-Dawley rats were injected in the left ventricle with approximately 5 x 10(9) colony-forming units/ml of retrovirus containing rat HO-1 antisense (LSN-RHO-1-AS) or control retrovirus (LXSN). After 3 mo, a 0.25-mm U-shaped silver clip was placed around the left renal artery. Animals were killed 3 wk later. Clipping the renal artery in LSN-RHO-1-AS rats did not result in increased HO-1 expression. In contrast to LXSN animals, 2K1C LSN-RHO-1-AS rats showed increased expression of cyclooxygenase 2 (COX-2) and higher 3-nitrotyrosine (3-NT) content as well as increased expression of the proapoptotic protein Apaf-1 and caspase-3 activity. Clipping the renal artery in LXSN rats resulted in increased expression of the antiapoptotic proteins Bcl-2 and Bcl-xl, while clipping the renal artery in LSN-RHO-1-AS rats did not change Bcl-2 levels and decreased the levels of Bcl-xl. Treatment of LSN-RHO-1-AS rats with cobalt protoporphyrin resulted in induction of renal HO-1, which was accompanied by decreases in blood pressure, COX-2, 3-NT, and caspase-3 activity, and increased expression of anti-apoptotic molecules (Bcl-2, Bcl-xl, Akt and p-Akt) in the clipped kidneys. These findings underscore the prominent role of HO-1 in counteracting apoptosis in this 2K1C renovascular hypertension model.
Olszanecki
Rafal
R
Dept. of Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
Rezzani
Rita
R
Omura
Shinji
S
Stec
David E
DE
Rodella
Luigi
L
Botros
Fady T
FT
Goodman
Alvin I
AI
Drummond
George
G
Abraham
Nader G
NG
D000818:Animals; D017209:Apoptosis / Q000235:genetics* / Q000502:physiology*; D001794:Blood Pressure / Q000502:physiology; D015153:Blotting, Western; D002467:Cell Nucleus / Q000502:physiology / Q000648:ultrastructure; D003401:Creatine / Q000097:blood; D051546:Cyclooxygenase 2 / Q000096:biosynthesis / Q000235:genetics; D053938:DNA Fragmentation; D015971:Gene Expression Regulation, Enzymologic / Q000502:physiology*; D005822:Genetic Vectors; D006419:Heme Oxygenase (Decyclizing) / Q000096:biosynthesis / Q000235:genetics; D051547:Heme Oxygenase-1 / Q000096:biosynthesis* / Q000235:genetics*; D006978:Hypertension, Renovascular / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D007674:Kidney Diseases / Q000201:enzymology / Q000473:pathology*; D011524:Protoporphyrins / Q000494:pharmacology; D016372:RNA, Antisense / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D012077:Renal Artery / Q000502:physiology; D012190:Retroviridae / Q000235:genetics; D015398:Signal Transduction / Q000502:physiology*; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism
D011524:Protoporphyrins; D016372:RNA, Antisense; C002744:3-nitrotyrosine; D014443:Tyrosine; C007095:cobaltiprotoporphyrin; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; C105245:heme oxygenase-2; D051546:Cyclooxygenase 2; D003401:Creatine